Haroon Hashmi, PhD

Chief Regulatory and Technical Officer

Haroon Hashmi joined Boston Pharmaceuticals in 2021 from Ziopharm Oncology, where he was Senior Vice President and Head of Regulatory Affairs providing strategic support to company’s gene and cell therapy platforms. Previously, he held roles of increasing responsibility at Alnylam Pharmaceuticals and Biogen. Haroon has 25 years of industry experience in global drug development and regulatory science in various therapeutic areas including neurology, hemophilia, pulmonary fibrosis, cardiology, and oncology. He has developed drugs of various therapeutic modalities including small molecules, biologics, siRNA, and cell (CAR-T and TCRs) and gene therapy. Haroon’s industry experience also includes establishing corporate offices in emerging markets, including assessment of commercial and business landscape, clinical development, and regulatory strategy for advancing product portfolio, hiring of key functional heads, and streamlining G&A functions. Haroon holds a Ph.D. in Public Health Epidemiology and a master’s degree in Experimental Medicine (hematology/oncology).